Impact of Uterine Leiomyoma Location on Uterine Artery Doppler Velocimetry
ULLADS
1 other identifier
observational
185
1 country
1
Brief Summary
Aim: Investigation of the impact of uterine leiomyoma location on uterine artery velocimetry Materials and Methods: It is a single-center prospective cohort study. The information regarding patients' demography, medical history, obstetric history, menstrual patterns, gynecological history, patients' complaints and physical examination recorded. For the patients who experience pain, visual analog scores were recorded. Total number of 185 patients have been administered for this study. They are further divided into four sub-groups according to the leiomyoma location. All measurements were recorded by the same doppler ultrasonography machine and same preset settings were used for each measurement. All examinations were performed by the same investigator. The measurements of uterus and myoma in ortogonal projections were recorded to calculate the volume by the prolate elipsoid formula. The location of each myoma were noted according to the FIGO classification. The recorded doppler ultrasonography indices included pulsatility index, resistance index and sistol/diastol ratio. IBM SPSS 27.0.0 was used for statistical analysis. Results: Mean values of PI, RI and S/D ratio were significantly lower in intramural myoma subgroup (p\<0,01). The doppler parameters were significantly higher for submucousal myoma compared to intramural and subserous myoma groups (p\<0,01) while there was no significant difference with control group. The impact of uterin leiomyoma location on uterin arter doppler findings were not altered by the effects of demographical features, age, BMI or history of c-section. The increased volumes of both uterus and myoma negatively correlated with the doppler indices while the history of c-section had a positive correlation with the doppler findings. The complaints of the patients at admission showed no effect on the doppler parameters. Conclusion: The uterin leiomyoma location has been showed to be significant factor on uterin doppler velocimetry. The leiomyomas with intramural component significantly decreased the resistance in uterine artery. Further research is required to fully understand the underlying mechanism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 4, 2025
CompletedFirst Submitted
Initial submission to the registry
June 10, 2025
CompletedFirst Posted
Study publicly available on registry
September 22, 2025
CompletedSeptember 22, 2025
June 1, 2025
7 months
June 10, 2025
September 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
the impact of uterine leiomyom location on uterine artery pulsatility index (PI)
The pulsatility index (PI) measurements compared amongst the study groups of different leiomyoma localizations (submucous, intramural, subserous) and control group
The doppler measurement is performed at the enrollment of the first patient up to one year
the impact of uterine leiomyom location on uterine artery resistance index (RI)
The resistance index (RI) measurements compared amongst the study groups of different leiomyoma localizations (submucous, intramural, subserous) and control group
The doppler measurement is performed at the enrollment of the first patient up to one year
the impact of uterine leiomyom location on uterine artery systolic/diastolic ratio (S/D)
The systolic/diastolic ratio measurements compared amongst the study groups of different leiomyoma localizations (submucous, intramural, subserous) and control group
The doppler measurement is performed at the enrollment of the first patient up to one year
Study Arms (4)
submucous leiomyoma
patients who are diagnosed with submucous leiomyoma
intramural leiomyoma
patients who are diagnosed with intramural leiomyoma
subserous leiomyoma
patients who are diagnosed with subserous leiomyoma
control
patients in the control group
Eligibility Criteria
patients who have appointments for the outpatient clinic of the hospital
You may qualify if:
- being older than 18 years old
- accepting the transvaginal ultrasound examination and having no impediment of having transvaginal ultrasound examination
- premenopausal status
- giving verbal and written consent to enroll
- being in the follicular phase of the menstrual cycle
You may not qualify if:
- being younger than 18 years old
- pregnancy or postpartum status
- postmenopausal status
- being virgin
- not accepting the transvaginal ultrasound examination or having an impeding condition
- having a disease causing circulaiton abnormalities, cardiac diseases, or other comorbidities effecting circulation
- diagnosed diabetes
- taking any of the hormonal drugs (such as oral contraceptives, levonorgestrel realisng intrauterine devices)
- diagnosed with any other gyneoclogical pathologies ( adenomyosis, endometriosis, adnexial masses, gynecologic malignancies, pelvic inflammatory diseases etc. )
- being in the phases of menstrual cycle other than follicular phase
- diagnosis with type 2-5 and type 8 leiomyoma uteri according to the FIGO classification
- having multiple uterine leiomyomas
- having a uterine leiomyoma larger than 500cm3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bakırköy Dr Sadi Konuk Eğitim ve Araştırma Hastanesi
Istanbul, bakırköy, 34147, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
June 10, 2025
First Posted
September 22, 2025
Study Start
October 1, 2024
Primary Completion
May 1, 2025
Study Completion
June 4, 2025
Last Updated
September 22, 2025
Record last verified: 2025-06